Literature DB >> 6381354

Review: total doses in fractionated radiotherapy--implications of new radiobiological data.

J F Fowler.   

Abstract

The total dose in radiotherapy has been adjusted in the past for different fractionation schedules by the use of empirical formulae such as NSD, TDF and CRE. It is now appropriate to consider fractionation factors which include more biological insight in their formulation than was possible earlier. It has become clear, from both clinical and experimental animal data, that the total dose in multi-fraction irradiations depends more critically on size of dose-per-fraction for late than for early damage to normal tissues. This difference has been interpreted as due to different shapes of the underlying dose-response curves. The late reactions respond with more curvature in the dose-response curve, i.e. with more repair capability at very low doses per fraction, than the early tissue reactions. A linear-quadratic relationship for the dose-response curves has been found to fit experimental data well, with few exceptions. This paper reviews this interpretation and explores some of its implications for radiotherapy and for radiobiology applied to therapy. Of many repair factors that have been suggested, the ratio alpha/beta (of the linear to the quadratic coefficients) is one that should be independent of the level of damage assayed. Values of alpha/beta of about 10 Gy have been reported for a number of early tissue responses but a range of values from about 1 to 5 or 6 Gy for late responses. It is a current challenge to radiobiology to explain why this difference occurs. Once such values are known for different tissues--and the dangers of premature assumptions are emphasized--calculations are possible which might be useful in radiotherapy as an alternative to NSD, TDF, CRE etc. Some data are presented on the magnitude of differences from these previously used empirical formulae, with a discussion about how easily detected the discrepancies might be in clinical practice. Applications to hypofractionation, hyperfractionation and accelerated fractionation are illustrated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381354     DOI: 10.1080/09553008414551181

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  13 in total

Review 1.  Cell kinetics and radiation pathology.

Authors:  J Denekamp; A Rojas
Journal:  Experientia       Date:  1989-01-15

2.  Radiation response of the mouse tongue epithelium.

Authors:  R Moses; J Kummermehr
Journal:  Br J Cancer Suppl       Date:  1986

Review 3.  The cellular basis of renal injury by radiation.

Authors:  M V Williams
Journal:  Br J Cancer Suppl       Date:  1986

4.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

5.  Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.

Authors:  Barbara Fisher; Wendy Seiferheld; Christopher Schultz; Lisa DeAngelis; Diane Nelson; S C Schold; W Curran; M Mehta
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

6.  Malignant melanoma metastatic to the larynx: treatment and functional outcome.

Authors:  B G Lanson; N Sanfilippo; B Wang; D Grew; M D DeLacure
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

Review 7.  Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

Authors:  R L Eakin; M I Saunders
Journal:  Ulster Med J       Date:  2000-11

8.  Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses.

Authors:  Hiromitsu Iwata; Naruhiro Matsufuji; Toshiyuki Toshito; Takashi Akagi; Shinya Otsuka; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2012-10-16       Impact factor: 2.724

Review 9.  Radiobiology of radiosurgery for the central nervous system.

Authors:  Antonio Santacroce; Marcel A Kamp; Wilfried Budach; Daniel Hänggi
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

10.  Results of radical radiotherapy for squamous cell carcinoma of the eyelid.

Authors:  Koji Inaba; Yoshinori Ito; Shigenobu Suzuki; Shuhei Sekii; Kana Takahashi; Yuuki Kuroda; Naoya Murakami; Madoka Morota; Hiroshi Mayahara; Minako Sumi; Takashi Uno; Jun Itami
Journal:  J Radiat Res       Date:  2013-06-07       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.